The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

The Rise and Fall of Primary Hyperparathyroidism: A Population-Based Study in Rochester, Minnesota, 1965-1992

Robert A. Wermers, MD; Sundeep Khosla, MD; Elizabeth J. Atkinson, MS; Stephen F. Hodgson, MD; W. Michael O'Fallon, PhD; and L. Joseph Melton III, MD
[+] Article, Author, and Disclosure Information

From the Mayo Clinic and Mayo Foundation, Rochester, Minnesota. Acknowledgment: The authors thank Mrs. Mary Roberts for assistance in preparing the manuscript. Grant Support: In part by research grants AG 04875 and AR 30582 from the National Institutes of Health. Requests for Reprints: L. Joseph Melton III, MD, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905. Current Author Addresses: Dr. Wermers: Wedgewood Medical Center, 120 Wedgewood Drive, Lincoln, NE 68510.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1997;126(6):433-440. doi:10.7326/0003-4819-126-6-199703150-00003
Text Size: A A A

Background: The introduction of routine measurement of serum calcium levels led to a sharp increase in the incidence of primary hyperparathyroidism in the early 1970s.

Objective: To evaluate the trends in the incidence of primary hyperparathyroidism since the mid-1970s.

Setting: Rochester and Olmsted County, Minnesota.

Design: Population-based descriptive study.

Patients: All residents of Rochester, Minnesota, who received an initial diagnosis of primary hyperparathyroidism between 1965 and 1992 were identified through the medical records linkage system of the Rochester Epidemiology Project. Included as persons having definite cases (92% of the total) were patients with pathologically confirmed hyperparathyroidism, hypercalcemia with inappropriately elevated parathyroid hormone levels, or hypercalcemia that had lasted for more than a year and had no cause other than primary hyperparathyroidism.

Measurements: Incidence rates were calculated and directly standardized to the population structure of white persons in the United States in 1990.

Results: From 1965 to June 1974 (the prescreening era), the age- and sex-adjusted incidence of primary hyperparathyroidism in Rochester was 15 cases per 100 000 person-years. After measurement of calcium levels was added to the automated serum chemistry panel in July 1974, the incidence increased to 112 per 100 000 person-years in 1975 and then decreased somewhat, reflecting a sweeping effect. Despite improved case ascertainment, however, the incidence rate has continued to decrease; in 1992, the incidence was 4 per 100 000 person-years. A few patients had complications that might have been caused by hyperparathyroidism (22% between 1965 and June 1974 and 6% thereafter), and survival was not impaired in either period. The maximum serum calcium levels did not change (P = 0.15).

Conclusions: The progressive decrease in the incidence of primary hyperparathyroidism is unexpected and suggests a significant change in the epidemiology of this disease.


Grahic Jump Location
Figure 1.
Incidence of definite and possible primary hyperparathyroidism among residents of Rochester, Minnesota, from 1965 to 1992. Top.dashed lineBottom.dashed line

Incidence curves are presented for total cases (solid line) and cases excluding those identified solely from the Mayo Clinic's Laboratory Information System ( ). Although the latter cases could be identified only from 1984 onward, cases recognized in this way could be dated back to the patient's initial elevated serum calcium level through review of existing medical records. Rates were adjusted for age and sex according to the population distribution of white persons in the United States in 1990. Incidence rates are presented for women (solid line) and men ( ). Rates were adjusted for age alone according to the population distribution of white persons in the United States.

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.